Stockton Group Overview
The Stockton Group (STK) develops and markets biopesticides based on plant extracts. It offers a variety of products adapted to specific regional particularities, biological parameters, and regulatory guidelines. Stocktons flagship product, Timorex Gold, controls a broad spectrum of crop diseases, demonstrating an efficacy similar to that of chemical fungicides. The product is suitable for both conventional and organic crops. The companys STK Aquamor veterinary unit develops plant-extract-based products designed to prevent infection and diseases in fish, shrimp, and other aquatic species, reducing fish mortality and environmental damage.
Latest News
growth-positive
North Carolina company partners with Israeli biopesticide producer
STK bio-ag technologies has partnered with Summit Agro U.S.A. for the exclusive distribution of STK products in the United States. Summit Agro will market STKs botanical-based biofungicides and biopesticides, as well as assume non-exclusive rights to sell Aviv biological fungicide. The partnership aims to provide fruit and vegetable growers in the USA with cutting-edge technologies for plant health and yield growth. The CEOs of both companies expressed excitement about the partnership and the expanded disease control options it offers.
Partners
Not applicable
STK (Stockton Group) is a global leader in the production and marketing of biological control solutions
The article discusses the use of GPS tracking and IoT in smart farming in Israel. It highlights the challenges faced by farmers in Israel and how technology can help overcome them. The article does not mention any specific company or provide any information about the impact on a company. The key theme of the article is the application of technology in agriculture. No specific issues, investors, or customers are mentioned. The date of the event described in the article is not provided. Confidence: 7
growth-positive
Stockton Takes First Step Into The U.S. Market
The Stockton Group has appointed Sarah Reiter as its Country Manager for the United States. Reiter has over 20 years of experience in the crop protection industry, with a focus on biopesticides. Her appointment signals Stocktons focus on the US market and her mission will be to create and grow Stocktons business in the US, with a focus on Timorex Gold and future portfolio products. The CEO of Stockton Group, Guy Elitzur, expressed confidence in Reiters ability to provide the leadership and direction needed for the companys US business. Stockton specializes in the development, manufacturing, and marketing of plant extract-based biopesticides and has a variety of products adapted to regional needs. Timorex Gold, Stocktons flagship product, is registered and sold in over 30 countries.
Management Changes
growth-positive
The Israel-Based Stockton Group Announces Top Management Changes in Preparation for a Future NASDAQ IPO and in Advance of Planned Acquisitions in the Biological Control Arena
Stockton, an Israeli company, has announced changes in its top management. Guy Elitzur, the companys CFO & COO, will be appointed as the CEO starting from January 1, 2016. Ziv Tirosh, the current CEO, will focus on the companys preparations for a Nasdaq IPO and its new focus on M&A activity. The company aims to accelerate growth through the acquisition of companies and technologies in the biocontrol arena. Stockton was founded by Peter Tirosh and has developed Timorex Gold, a commercial biopesticide. The recent investment from Sichuan Hebang will support the companys accelerated growth plans and the development of additional biocontrol products. Stockton has obtained regulatory approvals for Timorex Gold in the USA. The company will continue to be headquartered in Israel with Sichuan Hebangs Chairman acting as its controlling shareholder.
Management Changes
growth-positive
Stockton Group Receives $90 Million From China's Sichuan Hebang Corporation Limited in Exchange for a 51 Percent Stake in Company
Stockton Group Israel and Chinas Sichuan Hebang Corporation Limited have entered into an agreement where Hebang Group will acquire a 51 percent stake in Stockton Group for $90 million. This investment will enable Stockton to increase its research and development capabilities and market penetration in the biofungicide market. Hebang Group is a public Chinese company traded on the Shanghai Stock Exchange and is active in various industrial activities, including the agrochemical industry. This is Hebang Groups first investment outside of China. The transaction is expected to close within 90 days, subject to regulatory approvals in China.
Acquisition
| Sector | Agriculture & Food Technologies |
Funding
| Total funding | Undisclosed |
| Last funding | Undisclosed |
| Stage | Acquired |
| Rounds | 0 |
| Investors | 0 |
Team Members
4
Employees: 51-200
Web & Social Links
| Website | stk-ag.com/ |
| Careers | Careers page |
Locations
Ha-Mefalsim Street 17, Petah Tikva, Israel
Buenos Aires, Argentina
Guayaquil, Ecuador
Bogota, Colombia
4627 Fermi Place, Davis, CA 95618, USA
Photos & Videos
2 item(s)
